Solasia Pharma reports Japan half-year loss Y579.00M
For Japan half-year ended June 30, Solasia Pharma KK posted revenue of Y8.00 mln and pretax profit loss of Y579.00 mln, versus Y555.00 mln in 2025. Operating loss was Y570.00 mln.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.